NCT07338838 2026-01-14To Evaluate the Tolerability and Pharmacokinetics of TQB3142 for Injection in Patients With Advanced Malignant TumorsChia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 1 Not yet recruiting66 enrolled